D
David L. Veenstra
Researcher at University of Washington
Publications - 289
Citations - 18567
David L. Veenstra is an academic researcher from University of Washington. The author has contributed to research in topics: Cost effectiveness & Population. The author has an hindex of 56, co-authored 263 publications receiving 17276 citations. Previous affiliations of David L. Veenstra include University of California, San Francisco & University of California, Berkeley.
Papers
More filters
Journal Article
Determining unit cost values for health care resources in pharmacoeconomic studies
Journal ArticleDOI
Key drivers of family-level utility of pediatric genomic sequencing: a qualitative analysis to support preference research
Hadley Stevens Smith,Emily Bonkowski,Raymond Belanger Deloge,Amanda M. Gutierrez,Alva Recinos,Tara A. Lavelle,David L. Veenstra,Amy L. McGuire,Stacey Pereira +8 more
TL;DR: In this paper , the authors explored what is important to caregivers of pediatric patients regarding clinical genomic sequencing, with a focus on family-level considerations, and developed a framework of key drivers of utility consisting of four domains that influenced caregivers' decision making: underlying values, perceived benefits, perceived risks, and other pragmatic considerations regarding GS.
Journal ArticleDOI
Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study (Genetics in Medicine, (2019), 21, 5, (1100-1110), 10.1038/s41436-018-0308-x)
Ragan Hart,Barbara B. Biesecker,Carrie L. Blout,Kurt D. Christensen,Laura M. Amendola,Katie Bergstrom,Sawona Biswas,Kevin M. Bowling,Laura K. Conlin,Greg M. Cooper,Matthew C. Dulik,Kelly M. East,Jessica Everett,Candice R. Finnila,Arezou A. Ghazani,Marian J. Gilmore,Katrina A.B. Goddard,Gail P. Jarvik,Jennifer J. Johnston,Tia L. Kauffman,Whitley V. Kelley,Joel B. Krier,Katie L. Lewis,Amy L. McGuire,Carmit K. McMullen,Jeffrey Ou,Sharon E. Plon,Heidi L. Rehm,Heidi L. Rehm,Heidi L. Rehm,C. Sue Richards,Edward J. Romasko,Ane Miren Sagardia,Nancy B. Spinner,Michelle L. Thompson,Erin Turbitt,Jason L. Vassy,Jason L. Vassy,Benjamin S. Wilfond,David L. Veenstra,Jonathan S. Berg,Robert C. Green,Robert C. Green,Leslie G. Biesecker,Lucia A. Hindorff +44 more
Book ChapterDOI
Economic Issues and Genomic Medicine
TL;DR: The content of this chapter will help readers understand the multidisciplinary nature of the factors that will influence the value of genomic medicine, provide a framework for assessing these factors in a systematic, quantitative fashion, and highlight the importance of value-based reimbursement for genomic technologies for the future of genomic and personalized medicine.
Journal ArticleDOI
A Framework for Prioritizing Research Investments in Precision Medicine
TL;DR: In this article, the authors proposed a decision-relevant metrics to better understand and forecast the expected value of precision medicine (PM) in the context of individualized care (EVIC).